Zane Cohen Familial Gastrointestinal Cancer Registry and Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Am J Gastroenterol. 2010 Nov;105(11):2449-56. doi: 10.1038/ajg.2010.215. Epub 2010 Jun 8.
A novel cancer syndrome associated with biallelic mismatch repair (MMR) mutations has been described recently. Patients presenting with childhood-onset gastrointestinal (GI) cancers may carry biallelic MMR mutations and have a distinct phenotype from classic Lynch syndrome. The aim of this study was to characterize patients with GI small bowel and/or colorectal cancers (CRCs) who have germline biallelic MMR mutations.
A search of a Canadian GI cancer registry and literature review to identify patients with biallelic MMR was conducted.
The database identified 237 patients with intestinal cancer diagnosed before the age of 35 years. Five (2.1%) patients had biallelic MMR mutations. Overall, 32 individuals, from 29 families, with biallelic MMR gene mutations and GI cancers were identified by the registry and literature review. Among the 29 patients with CRCs, the mean age of first cancer diagnosis was 16.4 years (range: 5-28). More than one-third of patients had multiple colorectal adenomas (>10 polyps). Six individuals with biallelic MMR gene mutations have been reported with small bowel adenocarcinoma (mean age 20 years (range: 11-41)). Café-au-lait (CAL) macules were reported in 72% and, based on mutation analysis, consanguinity was suspected in 52% of kindred. Of the 29 kindred, 19 (66%) had PMS2 mutations, 6 (21%) had MSH6 mutations, 3 (10%) had MLH1 mutations, and 1 (3%) had MSH2 mutation.
Biallelic MMR mutations are an underrecognized cause of small bowel and colonic cancers in children and young adults. This distinct phenotype includes multiple adenomatous polyps and CAL skin lesions. It is important to identify such patients, so that families can be referred for genetic testing and counseling.
最近描述了一种与双等位基因错配修复(MMR)突变相关的新型癌症综合征。具有儿童期发病的胃肠道(GI)癌症的患者可能携带双等位基因 MMR 突变,并具有与经典林奇综合征不同的表型。本研究的目的是描述具有胃肠道小肠和/或结直肠癌(CRC)的患者,这些患者具有种系双等位基因 MMR 突变。
对加拿大胃肠道癌症登记处进行搜索,并对文献进行回顾,以确定具有双等位基因 MMR 的患者。
数据库确定了 237 名 35 岁以下诊断为肠癌的患者。5 例(2.1%)患者有双等位基因 MMR 突变。通过登记处和文献回顾,共确定了 32 名具有双等位基因 MMR 基因突变和胃肠道癌症的个体,来自 29 个家族。在 29 例 CRC 患者中,首次癌症诊断的平均年龄为 16.4 岁(范围:5-28)。超过三分之一的患者有多个结直肠腺瘤(>10 个息肉)。有 6 名具有双等位基因 MMR 基因突变的个体报告患有小肠腺癌(平均年龄 20 岁(范围:11-41))。72%的患者报告有牛奶咖啡斑(CAL),根据突变分析,52%的家族怀疑有近亲结婚。在 29 个家族中,19 个(66%)有 PMS2 突变,6 个(21%)有 MSH6 突变,3 个(10%)有 MLH1 突变,1 个(3%)有 MSH2 突变。
双等位基因 MMR 突变是儿童和年轻成人小肠和结肠癌症的一种未被充分认识的原因。这种明显的表型包括多发性腺瘤性息肉和 CAL 皮肤病变。重要的是要识别出此类患者,以便将其家庭转介进行基因检测和咨询。